登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Adverse events reported during miltefosine treatment.
Adverse events reported during miltefosine treatment.
收藏
NIAID Data Ecosystem
2026-05-02 收录
不良事件
药物安全监测
数据链接:
https://figshare.com/articles/dataset/Adverse_events_reported_during_miltefosine_treatment_/28025726
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Adverse events reported during miltefosine treatment.
应用场景:
创建时间:
2024-12-13
相关数据集
Adverse outcomes of the participants during hospitalization and after 3 months of follow up.
临床评估
不良事件
Adverse outcomes of the participants during hospitalization and after 3 months of follow up.
NIAID Data Ecosystem
3
0
Main characteristics of adverse events (AE) rates.
HIV药物安全性监测
不良事件
Main characteristics of adverse events (AE) rates.
NIAID Data Ecosystem
2
0
Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting system
药物安全监测
靶向抗癌药物警戒
Amivantamab stands as the pioneering bispecific antibody that targets both EGFR and MET, utilized in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR e
Figshare
2025-02-26 更新
1
0
Reasons of occurring severe adverse events.
药物安全监测
不良事件分析
(DOCX)
NIAID Data Ecosystem
3
0
The prescribing indicators grouped by serious harm outcome.
药物安全监测
医疗质量评估
The prescribing indicators grouped by serious harm outcome.
Figshare
2022-11-16 更新
1
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广